Mass spectrometric and spectroscopic studies of the nutritional supplement chromium(III) nicotinate

Biological Trace Element Research

Volumn 130, Issue 2, 2009, Pages 114-130

  Rhodes, Nicholas R ^a   Konovalova, Tatyana ^a   Liang, Qiaoli ^a   Cassady, Carolyn J ^a   Vincent, John B ^a  

^a UNIVERSITY OF ALABAMA   (United States)

Author keywords

Chromium nicotinate; Chromium(III); Electrospray; Mass spectrometry; Nicotinic acid

Indexed keywords

CHROMIUM; CHROMIUM DERIVATIVE; CHROMIUM NICOTINATE; HYDROXIDE; NICOTINIC ACID; OXYGEN; UNCLASSIFIED DRUG; WATER;

AQUEOUS SOLUTION; ARTICLE; CHEMICAL COMPOSITION; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG DETERMINATION; DRUG STRUCTURE; ELECTRON SPIN RESONANCE; ELECTROSPRAY MASS SPECTROMETRY; FAST ATOM BOMBARDMENT MASS SPECTROMETRY; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; SPECTROSCOPY; ULTRAVIOLET SPECTROSCOPY; CHEMISTRY;

CHROMIUM; DIETARY SUPPLEMENTS; MASS SPECTROMETRY; NIACIN; SPECTRUM ANALYSIS;

EID: 69849088867     PISSN: 01634984     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12011-009-8319-8     Document Type: Article

References (43)

1. Mertz W, Schwarz K (1955) Impaired intravenous glucose tolerance as an early sign of dietary necrotic liver degeneration. Arch. Biochem. Biophys 58:504-506.
2. Schwarz K, Mertz W (1957) A glucose tolerance factor and its differentiation from factor 3. Arch. Biochem. Biophys. 72:515-518.
3. Schwarz K, Mertz W (1959) Chromium(III) and the glucose tolerance factor. Arch. Biochem. Biophys. 85:292-295.
4. Stallings D, Vincent JB (2006) Chromium: A case study on how not to perform nutraceutical research. Curr. Topics Nutraceutical Res. 4:89-111.
5. Toepfer EW, Mertz W, Polansky MM, Roginski WW, Wolf WR (1977) Preparation of chromiumcontaining material of glucose tolerance factor activity from brewer's yeast extracts and by synthesis. J. Agric. Food Chem. 25:162-166.
6. Anderson RA, Mertz W (1977) Glucose tolerance factor: An essential dietary agent. Trends Biochem. Sci. 2:277-279.
7. Mertz W, Toepfer EW, Roginski EE, Polansky MM (1974) Present knowledge of the role of chromium. Fed. Proc. 33:2275-2280.
8. Davies DM, Holdsworth ES, Sherriff JL (1985) The isolation of glucose tolerance factors from brewer's yeast and their relationship to chromium. Biochem Med 33:297-311.
9. Held DD, Gonzalez-Vergara E, Goff HM (1984) Isolation of a non-chromium insulin-enhancing factor from brewer's yeast. Fed. Proc. 43:472.
10. Holdsworth ES, Neville E (1990) Effects of extracts of high- and low-chromium brewer's yeast on metabolism of glucose by hepatocytes from rats fed on high- or low-Cr diets. Brit. J. Nutr. 63:623-630.
11. Holdsworth ES, Kaufman DV, Neville E (1991) A fraction derived from brewer's yeast inhibits cholesterol synthesis by rat liver preparations in vitro. Brit. J. Nutr. 65:285-299.
12. Hwang DL, Lev-Ran A, Papoian T, Beech WK (1987) Insulin-like activity of chromium-binding fractions from brewer's yeast. J. Inorg. Biochem. 30:219-225.
13. Simonoff M, Shapcott D, Alameddine S, Sutter-Dub MT, Simonoff G (1992) The isolation of glucose tolerance factors from brewer's yeast and their relationship to chromium. Biol. Trace Elem. Res. 32:25-38.
14. Vincent JB (2001) The bioinorganic chemistry of chromium. Polyhedron 20:1-26.
15. Broderick WE, Legg JI (1985) Synthesis of the first stable nitrogen coordinated nicotinic acid chromium (III) complexes: cis- and trans-H[Cr(mal)2(nic-N)2]. Inorg. Chem. 24:3724-3725.
16. Green CA, Bianchini RJ, Legg JI (1984) Characterization of a stable chromium(III)-nicotinic acid complex by deuteron NMR. Inorg. Chem. 23:2713-2715.
17. Kingry KF, Royer AC, Vincent JB (1998) Nuclear magnetic resonance studies of chromium(III) pyridine carboxylate complexes. J. Inorg. Biochem. 72:79-88.
18. Broadhurst CL, Schmidt WF, Reeves JB III, Polansky MM, Gautschi K, Anderson RA (1997) Characterization and structure by NMR and FTIR spectroscopy, and molecular modeling of chromium (III) picolinate and nicotinate complexes utilized for nutritional supplementation. J. Inorg. Biochem. 66:119-130.
19. Anderson RA, Bryden NA, Polansky MM, Gautschi KJ (1996) Dietary chromium effects on tissue chromium concentrations and chromium absorption in rats. Trace Elem. Exp. Med. 9:11-25.
20. 51Cr picolinate in a rat model. Trace Elem. Electrolytes 11:182-186.
21. Stearns DM, Wise JP Sr., Patierno SR, Wetterhahn KE (1995) Chromium(III) picolinate produces chromosome damage in Chinese hamster ovary cells. FASEB J. 9:1643-1648.
22. Bagchi D, Bagchi M, Balmoori J, Ye X, Stohs SJ (1997) Comparative induction of oxidative stress in cultured J774A.1 macrophage cells by chromium picolinate and chromium nicotinate. Res. Commun. Mol. Pathol. Pharmacol. 97:335-346.
23. Bagchi D, Stohs SJ, Downs BW, Bagchi M, Preuss HG (2002) Cytotoxicity and oxidative mechanisms of different forms of chromium. Toxicology 180:5-22.
24. Shara M, Yasmin T, Kincaid AE, Limpach AL, Bartz J, Brenneman KA, Chatterjee A, Bagchi M, Stohs SJ, Bagchi DJ (2005) Safety and toxicological evaluation of a novel niacin-bound chromium(III) complex. J. Inorg. Biochem. 99:2161-2183.
25. Shara M, Kincaid AE, Limpach AL, Sandstrom R, Barrett L, Norton N, Bramble JD, Yasmin T, Tran J, Chatterjee A, Bagchi M, Bagchi D (2007) Long-term safety evaluation of a novel oxygen-coordinated niacin-bound chromium (III) complex. J. Inorg. Biochem. 101:1059-1069.
26. Evans GW, Pouchnik DJ (1993) Composition and biological activity of chromium-pyridine carboxylate complexes. J. Inorg. Biochem. 49:177-187.
27. Muzerall D, Westheimer FH (1955) 1-Benzyldihydronicotinamide-A model for reduced DPN. J. Am. Chem. Soc. 77:2261-2264.
28. Cooper JA, Anderson BF, Buckley PD, Blackwell LF (1984) Structure and biological activity of nitrogen and oxygen coordinated nicotinic acid complexes of chromium. Inorg. Chim. Acta 91:1-9.
29. Jensen NL (1989) Synthetic GTF chromium material and process therefore. WO 89/10357.
30. 4. Inorg. Chim. Acta 217:171-179.
31. Vincent JB (1994) Heteronuclear carboxylates of chromium(III) and iron(III): Mixtures or pure compounds. Inorg. Chem. 33:5604-5606.
32. 2O (Hpic = picolinic acid). Polyhedron 18:2891-2897.
33. 2O. Inorg. Chim. Acta 319:23-42.
34. Chaudhuri P, Winter M, Kuppers H-J, Wieghardt K, Nuber B, Weiss J (1987) General route to μ- hydroxo-bis(μ-acetato)-bridged heterometal dinuclear complexes. Syntheses, magnetic and redox properties, electronic spectra, and molecular structures of the Cr(III)-Co(II) and Cr(III)-Fe(II) species. Inorg. Chem. 26:3302-3310.
35. Low W, Offenbacher EL (1965) Electron spin resonance of magnetic ions in complex oxides: Review of ESR results in rutile, perovskites, spinels, and garnet structures. Solid State Phys. 17:135-216.
36. Stearns DM, Armstrong WH (1992) Mononuclear and dinuclear chromium(III) picolinate complexes. Inorg. Chem. 31:5178-5184.
37. Anderson RA, Polanksy MM, Bryden NA (2004) Stability and absorption of complexes of chromium and absorption of chromium histidine complexes by humans. Biol. Trace Elem. Res. 101:211-214.
38. Research Triangle Institute (2002) Project report on [14C]chromium picolinate monohydrate: disposition and metabolism in rats and mice submitted to the National Institute of Environmental Health Sciences, National Institutes of Health.
39. DiSilvestro RA, Dy E (2007) Comparison of acute absorption of commercially available chromium supplements. J. Trace Elem. Med. Biol. 21:120-124.
40. See also Lau FC, Bagchi M, Bagchi D, Preuss H (2007) Letter to the Editor: Comparison of acute absorption of commercially available chromium supplements. J. Trace Elem. Med. Biol. 21:274-275
41. and DiSilvestro RA (2007) Reply to the "letter to the Editor" by F.C. Lau et al. J. Trace Elem. Med. Biol. 21:275-276.
42. Zafra-Stone S, Bagchi M, Preuss HG, Bagchi D, Benefits of chromium(III) complexes in animal and human health. in The Nutritional Biochemistry of Chromium(III), Vincent JB, ed., Elsevier, Amsterdam, pp. 183-206 (2007).
43. Evans GW, Bowman TD (1992) Chromium picolinate increases membrane fluidity and rate of insulin internalization. J. Inorg. Biochem. 46:243-250.